0 references
A strain-guided trial of cardioprotection in early-stage breast cancer patients on anti-HER2 therapy (PROTECT HER2)
Cardio-Oncology2024Vol. 10(1), pp. 85–85
Fei Gong, Eli Grunblatt, Woo Bin Voss, Vibhav Rangarajan, Sasan R. Raissi, Kimberly Chow, Lua Jafari, Nikita P. Patel, Inga Vaitenas, Milica Marion, Haydee Ramirez, Manyun Zhao, Adin-Christian Andrei, Abigail S. Baldridge, Gillian Murtagh, Kameswari Maganti, Vera H. Rigolin, Nausheen Akhter
Abstract
https://clinicaltrials.gov/study/NCT02993198 . Start date: 4/2015. This trial included patients who were retrospectively registered.
Related Papers
- → Use of carvedilol in the treatment of heart failure(2003)1 cited
- Protective effects of carvedilol on rats cardiomyocytes exposed to adriamycin(2006)
- The study on effect of carvedilol in patients with congestive heart failure(CHF)(2004)
- Therapeutic efficacy of carvedilol in essential hypertension(2001)
- → ИСПОЛЬЗОВAНИЕ ПОТЕНЦИAЛA СОЦИAЛЬНЫХ ПAРТНЕРОВ В ПОДГОТОВКЕ БУДУЩИХ ПЕДAГОГОВ(2024)